GLP-1 Users Face Dual Stigma, Leading to Hidden Treatment and Altered Medical Choices
A new study reveals that individuals taking GLP-1 medications face a 'double stigma' for their body size and their choice of medical treatment. This social pressure leads many patients to hide their medication use, alter dosing without supervision, or seek alternative providers to avoid judgment. Clinicians are urged to use empathetic, open-ended communication to counteract these barriers and ensure patients feel safe discussing their health goals.
